Neurophotonics Market Forecast Report: Size, Share, and Opportunities 2030

 What Is the Estimated Market Size and CAGR of the Neurophotonics Market for the Period 2026–2030?

 The neurophotonics market size has grown rapidly in recent years. It will grow from $1.92 billion in 2025 to $2.14 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing demand for noninvasive neuroimaging, growing adoption of optical imaging in neuroscience research, rising prevalence of neurological disorders driving diagnostic needs, expanding use of brain mapping technologies in academic institutions, and growing investment in biomedical photonics by government and private organizations.

 
 The neurophotonics market size is expected to see rapid growth in the next few years. It will grow to $3.28 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing focus on early detection of mental health and neurodegenerative diseases, rising adoption of optical neuromodulation for therapeutic applications, growing integration of artificial intelligence in neuroimaging data analysis, expanding clinical trials adopting photonic brain monitoring tools, and increasing commercialization of advanced laser-based neurotechnology platforms. Major trends in the forecast period include technology advancements in optical coherence and functional spectroscopy, innovations in multimodal brain imaging systems, rapid developments in noninvasive neural stimulation technology, continuous research and development in photonic brain signal monitoring, and integration of cloud-based and real-time analytics for neuroscience data.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=30679&type=smp
 
 Which Key Dynamics Are Contributing to the Expansion of the Neurophotonics Market?
 The rising demand for non-invasive imaging techniques is expected to propel the growth of the neurophotonics market going forward. Non-invasive imaging techniques are methods that allow researchers and clinicians to visualize internal neurological structures and activity without surgery or penetrating the body, using technologies such as MRI, fMRI, EEG, MEG, and optical imaging. The rise in demand for non-invasive imaging techniques is due to increasing requirements in neuroscience research for safer, repeatable, and high-resolution tools that can study brain structure and function without risk to subjects. Neurophotonics supports this demand by providing advanced light-based imaging technologies that enable precise visualization of neural circuits and real-time monitoring of brain activity. For instance, in July 2025, according to the National Institutes of Health (NIH) BRAIN Initiative, a US-based government research initiative, in 2023, the ultra-high-resolution Connectome 2.0 MRI scanner was developed. Over the next decade, the market is forecast to expand at a compound annual growth rate (CAGR) of roughly 10.7–11.2% from 2025 to 2033, with projections indicating a market size of around USD 5.1 billion by 2033 as light based neuroimaging gains broader clinical and research adoption. Therefore, the rising demand for non-invasive imaging techniques is driving the growth of the neurophotonics market.
 
 What Are the Primary Market Segments in the Neurophotonics Market?
 The neurophotonics market covered in this report is segmented — 
 
 1) By Component: Devices And Equipment, Software And Data Analysis Platforms, Consumables And Accessories, Services
 2) By Technology: Optical Coherence Tomography, Laser Stimulation And Modulation Systems, Photoacoustic Imaging, Optogenetics, Fluorescence Imaging, Functional Near-Infrared Spectroscopy, Two-Photon Microscopy
 3) By Distribution Channel: Online Platforms, Distributors And Channel Partners, Direct Sales
 4) By Application: Research, Diagnostics, Therapeutics
 5) By End-User: Academic And Research Institutes, Hospitals And Clinics, Pharma And Biotech Companies
 
 Subsegments:
 1) By Devices And Equipment: Optical Neuroimaging Devices, Laser Stimulation Systems, Photonic Sensors, Fiber Optic Instruments, Imaging Accessories
 2) By Software And Data Analysis Platforms: Neuroimaging Data Analysis Software, Brain Mapping Software, Visualization Platforms, Signal Processing Software, Cloud Based Analytics Platforms
 3) By Consumables And Accessories: Optical Fibers, Imaging Reagents, Laser Safety Equipment, Photonic Consumables, Calibration Kits
 4) By Services: Training And Support Services, Research And Development Services, Clinical Consultation Services, Data Management Services
 
 Which Disruptive Trends Are Reshaping the Competitive Landscape of the Neurophotonics Market?
 Major companies operating in the Neurophotonics market are focusing on developing advanced tools, such as optogenetic and optical sensor instruments, to enhance neural activity measurement, control, and translational neuroscience research. Optogenetic and optical sensor instruments refer to engineered light delivery systems and optical sensors that can stimulate and record neural activity at cellular resolution, providing critical insights into nervous system function. For instance, in September 2025, the NIH Common Fund Venture Program awarded grants under the Advancing Non Invasive Optical Imaging Approaches for Biological Systems initiative to support the development of real-time optical imaging systems capable of deep tissue imaging and molecular contrast, including methods such as synthetic wavelength imaging. These federally funded programs facilitate the creation of next-generation neurophotonics tools that industry players can adopt and commercialize for research and clinical applications.
 
 Who Are the Established and Emerging Companies Competing in the Neurophotonics Market?
 Major companies operating in the neurophotonics market are Hitachi Ltd., Olympus Corporation, Coherent Corp., Bruker Corporation, HORIBA Ltd., Hamamatsu Photonics K.K., Leica Microsystems GmbH, Thorlabs Inc., Spectra-Physics, NeuroLight Technologies Ltd., Inscopix Inc., NeuroNexus Technologies Inc., Intelligent Imaging Innovations Inc., Femtonics Limited, NIRx Medical Technologies LLC, Hemophotonics S.L., Carl Zeiss AG, Artinis Medical Systems B.V., Plexon Inc., Vielight Inc., Nanoscope Technologies LLC, Neurophotometrics Ltd. 
 
 Get the detailed neurophotonics market report today
 https://www.thebusinessresearchcompany.com/report/neurophotonics-market-report
 
 Which Region Is Expected to Dominate the Neurophotonics Market During the Forecast Period?
 North America was the largest region in the neurophotonics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurophotonics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company